Table 2.

Liver enzymes and adverse events after 12 weeks of ART

Parameters	Group A (n = 81)	Group B (n = 41)	p value
Liver enzymes
ALP at week 12, U/l, median (IQR)	81.5 (65.0–116.8)	77.0 (112.0–132.5)	0.011
AST at week 12, U/l, median (IQR)	20.3 (25.0–33.8)	22.0 (27.5–44.3)	0.351
ALT at week 12, U/l, median (IQR)	17.0 (25.0–38.8)	22.0 (26.0–46.0)	0.329
TB at week 12, mg/dl, median (IQR)	0.3 (0.4–0.5)	0.3 (0.4–0.5)	0.907
Adverse events
Skin rashes	6 (7.4%)	0 (0%)	0.096
Clinical hepatitis	0 (0%)*	1 (2.4%)	0.336

* add 0.5 to calculate p value